Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Evidence: Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan

version: 4; Last updated: 2025-09-13 18:18:20+0000

url: https://fevir.net/resources/Evidence/397479

identifier: FEvIR Object Identifier/397479

name: Evidence_for_Results_for_Add_on_Amlodipine_at_6_weeks_in_GroupAssignment_Quadpill_vs_Candesartan

title: Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan

citeAs:

Evidence for Results for Add-on Amlodipine at 6 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397479. Revised 2025-09-13. Available at: https://fevir.net/resources/Evidence/397479. Computable resource at: https://fevir.net/resources/Evidence/397479#json.

status: Active

author: Brian S. Alper, MD, MSPH:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

RelatesTos

-TypeTarget[x]
*Part OfOutcome Measure Report for QUARTET USA Trial

description:

This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.

variableDefinition

variableRole: Population

observed: the study group

variableDefinition

variableRole: Exposure

observed: GroupAssignment: Quadpill vs. Candesartan

variableDefinition

variableRole: Outcome

observed: Add-on Amlodipine at 6 weeks

statistic

statisticType: odds ratio

quantity: 0.92

numberAffected: 22

SampleSizes

-ExtensionNumberOfParticipantsKnownDataCount
*6262

attributeEstimate

type: confidence interval

level: 0.95

range: 0.02-0.41

attributeEstimate

type: p-value

quantity: 0.003